“If successful, the global public health value of this trial result would be immense given the low cost and availability of this medicine,” said Professor Matthew Hotopf, Director of the NIHR Maudsley BRC, in a statement from King’s College London, the lead institution conducting the study.
Ibuprofen being studied as possible lifesaver for coronavirus-related respiratory failure
Prepare Now Before its too Late
Discover where products are available & compare prices
